title: Review: The biological basis of antipsychotic response in schizophrenia.
abstract: Schizophrenia is a severe mental illness affecting approximately 1% of the population worldwide. Antipsychotic drugs are effective in symptom control in up to two-thirds of patients, but in at least one-third of patients the response is poor. The reason for this is not clear, but one possibility is that good and poor responders have different neurochemical pathologies, and may therefore benefit from different treatment approaches. In this selective review we summarise research findings investigating the biological differences between patients with schizophrenia who show a good or a poor response to treatment with antipsychotic drugs.
authors: Institute of Psychiatry, King's College London, London SE5 8AF, UK. james.stone@iop.kcl.ac.uk
authors: James M
authors: JM
authors: Stone
authors: Marie
authors: M
authors: Raffin
authors: Paul
authors: P
authors: Morrison
authors: Philip K
authors: PK
authors: McGuire
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D015415:Biomarkers; D001921:Brain / Q000473:pathology; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012559:Schizophrenia / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology*
chemical_list: D014150:Antipsychotic Agents; D015415:Biomarkers